<DOC>
	<DOC>NCT00613756</DOC>
	<brief_summary>The survey is conducted to collect safety and effectiveness information targeting patients who have both Parkinson's disease and renal dysfunction treated with Pramipexole in the daily clinical settings in Japan.</brief_summary>
	<brief_title>Special Survey on PD Patients With Renal Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Patients with Parkinson's disease who have renal dysfunction with pretreatment creatinine clearance =&lt;70mL/min or whose renal dysfunction was determined by the physician</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>